Healthcare

Australian medical imaging technology company 4DMedical Limited (ASX:4DX) has continued attracting significant market attention as its respiratory imaging platform gains momentum across clinical, commercial, and regulatory fronts globally. Over recent months, the company has delivered a series of developments spanning advanced clinical validation, major …

Fisher & Paykel Healthcare (ASX:FPH) delivered a sharp upward move in the latestTrading sessionon 26 May 2026, with its share price rising to AUD 30.05, up 9.15% intraday (+AUD 2.52). The rally marked one of the strongest single-day performances for the stock in recent …

Fisher & Paykel Healthcare (ASX:FPH) attracted strong investor attention on 26 May after its shares climbed 9.15% to close at AUD 30.05. The rally came after the medical device manufacturer released its FY26 result, which was broadly in line with market expectations but appeared …

Healthcare technology company ResMed (ASX:RMD) has remained firmly on investor watchlists as the global conversation around sleep health, obesity treatment, digital healthcare, and home-based care continues to accelerate. While market sentiment around sleep apnea treatment companies faced pressure over the past year amid concerns …

CleanSpace Holdings Ltd (ASX:CSX) shares declined 15.00% to AUD 0.34 during the afternoon session on 26 May 2026 after the respiratory protection equipment manufacturer released a FY26 trading update that pointed to more difficult market conditions across several regions. The stock has also fallen …

PainChek Ltd (ASX:PCK) has lodged an Appendix 3X – Initial Director’s Interest Notice – confirming the appointment of Lilian Bianchi to the company’s Board effective 25 May 2026. The filing, released to the ASX on 26 May 2026, represents a routine governance disclosure under …

Aroa Biosurgery Limited (ASX:ARX) traded at A$0.63, rising 1.61% on the day of its FY26 results release. Over the past year, the stock has increased approximately 36.96%, reflecting improving financial performance and sustained revenue growth momentum across its surgical reconstruction product portfolio.